Compounded semaglutide costs less because it doesnt include: pharmaceutical company brand development costs, extensive marketing expenses, patent-protected pricing, or insurance markup
The FDA stated that it also considered information from telehealth companies, pharmacy compounders, associations representing pharmacy compounders and outsourcing facilities, and individuals. In an attempt to avoid disruptions to patient treatment, the FDA intends to use its enforcement discretion over those persons or facilities compounding semaglutide injection products pursuant to Section 503A or 503B of the Food, Drug, and Cosmetic Act (FDCA), as follows: While these periods of enforcement discretion are longer than the discretion period detailed in the FDAs guidance for 503B outsourcing facilities (which is normally 60 days after the drug is removed from the FDAs shortage list), the discretion periods for compounded semaglutide injection products mirror what we recently saw when the FDA deemed that the tirzepatide shortage was resolved
compounding pharmacies or retail pharmacies Ongoing monitoring: Regular follow-up appointments to adjust dosing and track progress Transparent pricing: Clear, all-inclusive cost structures without hidden consultation fees Patient education: Guidance on injection technique, storage, side effect management, and lifestyle integration Not all online clinics meet these standards
We disclaim any liability for direct, indirect, incidental, or consequential damages resulting from the use of our products outside of the stated research purpose
